Home › Funds › BOOTHBAY FUND MANAGEMENT, LLC › PCVX

BOOTHBAY FUND MANAGEMENT, LLC position in PCVX

VAXCYTE INC · Health Care

BOOTHBAY FUND MANAGEMENT, LLC reported holding 534,163 shares of PCVX (VAXCYTE INC) in its Q2 2026 13F filing — a position valued at US$31.1M, representing 0.62% of its reported portfolio and ranking #9 among its reported holdings. BOOTHBAY FUND MANAGEMENT, LLC has disclosed PCVX holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)534.16K sh
Reported value held$31.05M
Portfolio Weight0.62%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BOOTHBAY FUND MANAGEMENT, LLC's PCVX position evolved

BOOTHBAY FUND MANAGEMENT, LLC first disclosed a stake in PCVX in Q3 2023 at 27,919 shares (US$1.4M). The position peaked in Q2 2026 at 534,163 shares, worth US$31.1M. Across 8 filings, BOOTHBAY FUND MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 534,163 shares valued at US$31.1M — an increase of 332,863 shares quarter over quarter.. Notable position changes include a 287% increase in Q4 2025 (shares rose 26% over the following quarter), a 60% trim in Q1 2026 (shares were roughly flat over the following quarter), a 165% increase in Q2 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 27.92K $1.42M New
Q3 2024 3.60K $411.37K New
Q1 2025 65.16K $2.46M New
Q2 2025 103.27K $3.36M Add
Q3 2025 128.73K $4.64M Add
Q4 2025 497.74K $22.97M Add
Q1 2026 201.30K $11.70M Reduce
Q2 2026 534.16K $31.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 36 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has BOOTHBAY FUND MANAGEMENT, LLC held PCVX?

BOOTHBAY FUND MANAGEMENT, LLC has disclosed PCVX holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is BOOTHBAY FUND MANAGEMENT, LLC's current position in PCVX?

As of Q2 2026, BOOTHBAY FUND MANAGEMENT, LLC holds 534.16K shares of PCVX (VAXCYTE INC), valued at $31.05M, representing 0.62% of its reported portfolio and ranking #9.

Has BOOTHBAY FUND MANAGEMENT, LLC been buying or selling PCVX?

In the latest 13F filing (Q2 2026), BOOTHBAY FUND MANAGEMENT, LLC increased its position in PCVX. The position peaked in Q2 2026 at 534.16K shares.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.